A 58-year-old man with chronic heart failure (NYHA Class III) is on lisinopril, metoprolol, and spironolactone. His ejection fraction is 28%. Regarding the pharmacological properties of heart failure drugs, all of the following statements are correct EXCEPT:

Explanation

## Mechanism of Action and Mortality Benefit ### Correct Statements (Options 0–2) **Key Point:** ACE inhibitors, beta-blockers, and aldosterone antagonists have proven mortality benefit in systolic heart failure through neurohormonal modulation. | Drug Class | Mechanism | Mortality Benefit | Evidence | |---|---|---|---| | ACE Inhibitors | Block angiotensin II → ↓ vasoconstriction, ↓ aldosterone | Yes (proven) | CONSENSUS, SOLVD trials | | Beta-blockers | ↓ HR, ↓ contractility, ↓ arrhythmias | Yes (proven) | CIBIS, MERIT-HF, COPERNICUS | | Aldosterone Antagonists | Block aldosterone → ↓ Na+ retention, ↓ fibrosis | Yes (proven) | RALES trial | **High-Yield:** All three drug classes (ACE-I, beta-blockers, aldosterone antagonists) are pillars of guideline-directed medical therapy (GDMT) for systolic HF and have Class I recommendations for mortality reduction. ### Why Option 3 Is Incorrect **Warning:** Diuretics do NOT reduce mortality in heart failure — they are **symptomatic agents only**. **Clinical Pearl:** Diuretics (loop, thiazide) improve dyspnea, orthopnea, and peripheral edema by reducing preload and pulmonary congestion, but they do NOT modify disease progression or improve survival. They are used for **symptom relief** in volume-overloaded patients, not as disease-modifying therapy. **Key Point:** The evidence base for diuretic monotherapy shows no survival benefit. Randomized trials (e.g., PARADIGM-HF) demonstrate that neurohormonal antagonists (ACE-I, ARBs, beta-blockers, aldosterone antagonists) are the cornerstone of mortality reduction. ### Mnemonic for HF Drug Classes **ABCD of Heart Failure:** - **A** = ACE inhibitors / ARBs (mortality ↓) - **B** = Beta-blockers (mortality ↓) - **C** = Aldosterone antagonists (mortality ↓) - **D** = Diuretics (symptom relief only, no mortality benefit) **Tip:** On exams, always distinguish between **symptom-relieving drugs** (diuretics, nitrates) and **disease-modifying drugs** (ACE-I, beta-blockers, aldosterone antagonists, SGLT2 inhibitors).